Skip to main content
. 2018 Sep 20;19(1):813. doi: 10.4102/sajhivmed.v19i1.813

TABLE 1-A1.

Characteristics of HIV-uninfected and HIV-infected individuals after adjusting for waist circumference.

Variable HIV-uninfected N = 114 HIV-infected N = 114 p
Cardiovascular measurements
SBP, mmHg 133 ± 23.5 127 ± 23.5 0.057
DBP, mmHg 87 ± 13.2 83 ± 13.2 0.029
PP, mmHg 46 ± 14.6 43 ± 14.6 0.278
MAP, mmHg 102 ± 15.9 97 ± 15.9 0.032
cSBP, mmHg 128 ± 18.7 121 ± 18.9 0.004
Biochemical variables
TC, mmol/L 4.49 ± 11.9 4.56 ± 11.9 0.645
LDL-c, mmol/L 2.72 ± 16.4 2.74 ± 16.4 0.911
TG, mmol/L 1.12 (1.02; 1.23) 1.15 (1.05; 1.27) 0.642
HDL-c, mmol/L 1.29 (1.21; 1.38) 1.27 (1.20; 1.36) 0.731
TG/HDL-C ratio 0.87 (0.76; 0.98) 1.10 (0.80; 1.03) 0.603
Glucose, mmol/L 5.23 (5.01; 5.47) 5.22 (4.50; 5.43) 0.937
HbA1c, % 5.84 (5.68; 6.00) 5.53 (5.38; 5.68) 0.007
CRP, mg/L 0.99 (0.67; 1.49) 1.54 (1.03; 2.30) 0.146
Renal markers
CrCl, mL/min 109 (104; 114) 105 (100; 110) 0.304
eGFR, mL/min/1.73 m2 102 (101; 106) 103 (100; 105) 0.573
uACR, mg/mmol 1.50 (1.21; 1.87) 1.80 (1.44; 2.24) 0.270

Data are adjusted means ± SD or -95% and +95% CI for logarithmically transformed variables. SD, standard deviation; CI, confidence interval; HIV, human immunodeficiency virus; N, number of participants; DBP, diastolic blood pressure; SBP, systolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; cSBP, central systolic blood pressure; TC, total cholesterol; LDL-cholesterol, low density lipoprotein cholesterol; HDL-cholesterol, high-density lipoprotein cholesterol; TG:HDL-C, triglycerides: High-density lipoprotein cholesterol; CRP, C-reactive protein; CrCl, creatinine clearance; eGFR, estimated glomerular filtration rate; uACR, urinary albumin-creatinine ratio.